지에프씨생명과학

Business Overview

GFCC Life Sciences operates two main business units: the Material Business Unit, which develops innovative cosmetic ingredients using skin microbiome and exosome technologies, and the Clinical Business Unit, which provides human efficacy testing services for cosmetics. The Material Business Unit leverages a library of over 2,000 strains and proprietary patents to produce high-value raw materials, expanding into the growing skin booster market. The Clinical Business Unit benefits from increased demand for efficacy verification due to regulatory changes, driving sustained revenue growth.